Pregled bibliografske jedinice broj: 887627
Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients
Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients // BMC Cardiovascular Disorders, 17 (2017), 195-1 doi:10.1186/s12872-017-0633-z (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 887627 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients
Autori
Krasniqi, Xhevdet ; Berisha, Blerim ; Gashi, Masar ; Kocinaj, Dardan, Jashari, Fisnik ; Vincelj, Josip
Izvornik
BMC Cardiovascular Disorders (1471-2261) 17
(2017);
195-1
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Apelin ; Myocardial infarction ; Major adverse cardiac events
Sažetak
During acute myocardial infarction, phosphorylated TnI levels, Ca2+ sensivity and ATPase activity are decreased in the myocardium, and the subsequent elevation in Ca2+ levels actovates protease I (caplain I), leading to the proteolytic degradation of troponins. Concurently, the levels of apelin and APJ expression are increased by limiting myocardial injuri. In this prospective observational study, 100 consecutive patients with ST-elevation acute myocardial infarction were included. Patients meeting the 3 following criteria were included in our study: (1) continuous chest pain lasting >30 min, (2) observation of ST-segment elevation of more than 2 mm in two adjacend leads by ECG, (3) increased cardiac troponin I levels, and (4) patients who undferwent reperfusion therapy. We evaluated the levels of apelin-12 and troponin I on the first and seventh days after reperfusion therapy in all patients. Apelin-12 was inversely correlated with troponin I levels (Spearman's correlation= -0.40) with a p value <0.001. There was variability in the apelin values on the seventh day (Kruskal-Wallis test) based on major adverse cardiac events (MACE) (p=0.012). Using ROC curve analyses, a cut-off value of >2.2 for the association of apelin with MACE was determined, and the AUC was 0.71 (95% CI, 0.58- 0.84). Survival analysis using the Kaplan-Meier method showed a lower rate of MACE among patients with apelin levels >2.2 (p=0.002), and the ROC curve analysis showed a statistically significant difference in the are under the curve (p=0.004). The influence of apelin levels on troponin levels in the acute phase of STEMI in inversely correlated, whereas in the non-acute phase, low apelin values were associated with a high rate of MACE.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Dubrava",
Zdravstveno veleučilište, Zagreb,
Medicinski fakultet, Osijek,
Sveučilište J. J. Strossmayera u Osijeku
Profili:
Josip Vincelj
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- MEDLINE
- Scopus, Embase, Global Health